Zurueck zur Suche

Reporte zur Charge UJ453AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

1Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 1

VAERS 2713205

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ453AA

kritisch
Staat
MI
Alter
79,0
Geschlecht
M
Eingang
13.11.2023
Impfdatum
17.10.2022
Beginn
29.08.2023
Tage bis Beginn
316,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory failure Asthenia Atrioventricular block first degree Balance disorder Blood sodium decreased C-reactive protein increased COVID-19 Chest X-ray abnormal Confusional state Cough Electrocardiogram PR prolongation Electrocardiogram T wave abnormal Electrolyte depletion Electrolyte substitution therapy Fall Fibrin D dimer increased Haemoglobin Hyponatraemia

Symptomtext

BRIEF OVERVIEW: Admission Date: 8/29/2023 Discharge Date: 9/3/2023 Discharge Disposition: home health care svc DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 80y/o male with a past medical history of BH. CAD, dilantin toxicity, epilepsy, dilantin toxicity, neuropathy, and sleep apnea who presented for increasing weakness. Patients symptoms began 3 days prior to admission with increasing weakness and confusion, intermittent fevers, balance issues, and a fall without LOC or head injury. Patient additionally began to develop a cough prior to presentation to the ED. With patient' s change from baseline, family called EMS to bring patient in. Upon evaluation, patient was put on 2L of oxygen on the way to the ED. Patient did not wear oxygen at baseline. In the Emergency Department, patient presented with a fever of 101.8, tachypnea, and SpO2 at 91% on 2L NC. Basic labs were ordered and revealed a mild normocytic anemia with hgb 13.2, elevated CRP of 24.1, and a mild hyponatremia 133 but were otherwise benign. 4-plex was completed and came back COVID positive. Patient was placed in respiratory precautions. EKG findings demonstrated increased PR interval from known first degree AV block, PACs, and T wave abnormality, but not significantly different from previous findings. CXR revealed mild pulmonary vascular congestion but no signs of pneumonia. D-dimer was slightly elevated at 660. Hospitalist team was contacted for further evaluation. Upon admission patient was started on remdesivir and lasix. Patient was placed in seizure precautions with his history of having seizures 1-2 times weekly. PT/OT evaluation recommending SAR, but on day 2 of admission noting that pt is improving and could potentially progress to home. Pt had a controlled fall on the morning of 9/1/2023 where he misstepped from the practice stairs, and PT was able to lower him to the ground. He sustained no injuries. On reevaluation on day of dc felt safe for dc home with HHC physical therapy . Rec on dc 2 person assist with stairs and standby assist with other ambulation. Electrolytes were monitored and repleted PRN throughout the admission. Patient clinically improved and hemodynamically stable for discharge. Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Personal history of fall Coronary artery disease involving native heart without angina pectoris, unspecified vessel or lesion type Benign prostatic hyperplasia without lower urinary tract symptoms Nonintractable epilepsy without status epilepticus, unspecified epilepsy type (HCC) Cardiac murmur Treatment-emergent central sleep apnea on ASV Obstructive sleep apnea Class 2 severe obesity with serious comorbidity and body mass index (BMI) of 38.0 to 38.9 in adult, unspecified obesity type Chronic maxillary sinusitis Polyneuropathy associated with underlying disease (HCC) Depressive disorder Hypertension Herpes zoster Hyperlipidemia Allergic conjunctivitis of both eyes PLMD (periodic limb movement disorder) Excessive daytime sleepiness Hypersomnia BiPAP (biphasic positive airway pressure) dependence GERD without esophagitis Tremor Acute hypoxemic respiratory failure due to COVID-19 (HCC) Anemia Pancytopenia (HCC) History of COVID-19 Platelets decreased (HCC)
Andere Medikamente
aspirin 81 MG EC tablet citalopram (CELEXA) 40 mg tablet cyanocobalamin 1000 MCG tablet divalproex (DEPAKOTE ER) 500 mg 24 hr tablet doxazosin (CARDURA) 4 MG tablet gabapentin (NEURONTIN) 600 MG tablet levETIRAcetam (KEPPRA) 500 mg tablet L
Allergien
Flonase [Fluticasone]Seizure Sulfa DrugsHives Ofloxacin Sulfamethoxazole Vicodin Hp [Hydrocodone-acetaminophen
Vorherige Impfungen
-